(Q34976750)

English

Pathophysiological and clinical relevance of circulating levels of cardiac natriuretic hormones: are they merely markers of cardiac disease?

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1 reference

Europe PubMed Central

Pathophysiological and clinical relevance of circulating levels of cardiac natriuretic hormones: are they merely markers of cardiac disease? (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

pathophysiology

1 reference

based on heuristic

inferred from title

1

object named as

Aldo Clerico

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

publication date

1 August 2002

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Clinical Chemistry and Laboratory Medicine

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

752-760

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Pathophysiologic relevance of measuring the plasma levels of cardiac natriuretic peptide hormones in humans

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.129

21 January 2018

Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.129

21 January 2018

The role of the natriuretic peptides in the cardiovascular system.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.129

21 January 2018

The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.129

21 January 2018

B-type natriuretic peptide levels: a potential novel "white count" for congestive heart failure

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.129

21 January 2018

Natriuretic peptides in the pathophysiology of congestive heart failure

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.129

21 January 2018

Introducing a new role for BNP: as a general indicator of cardiac structural disease rather than a specific indicator of systolic dysfunction only

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.129

21 January 2018

Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.129

21 January 2018

Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.129

21 January 2018

Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.129

21 January 2018

Brain natriuretic peptide blood levels in the differential diagnosis of dyspnea.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.129

21 January 2018

Guidelines for the diagnosis and treatment of chronic heart failure

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.129

21 January 2018

Mechanical and neuroendocrine regulation of the endocrine heart.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.129

21 January 2018

Alterations in metabolic clearance of atrial natriuretic peptides in heart failure: how do they relate to the resistance to atrial natriuretic peptides?

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.129

21 January 2018

Local adenovirus-mediated transfer of C-type natriuretic peptide suppresses vascular remodeling in porcine coronary arteries in vivo

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.129

21 January 2018

Turnover studies on cardiac natriuretic peptides: methodological, pathophysiological and therapeutical considerations

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.129

21 January 2018

Therapeutic benefits of increasing natriuretic peptide levels

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.129

21 January 2018

Atrial natriuretic peptide mimetics and vasopeptidase inhibitors

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.129

21 January 2018

The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.129

21 January 2018

Cardiovascular consequences of the aging process

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.129

21 January 2018

Where are all the women with heart failure?

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.129

21 January 2018

Estrogen, natriuretic peptides and the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.129

21 January 2018

Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.129

21 January 2018

Vasoactive peptide release in relation to hemodynamic and metabolic changes during rapid ventricular pacing

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.129

21 January 2018

Identifiers

10.1515/CCLM.2002.129

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34976750&oldid=1744399835"